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Abstract
The aim of this study was to characterize Staphylococcus pseudintermedius for its antimicrobial
resistance and virulence factors with a special focus on methicillin-resistant (MRSP) strains isolated
from sick dogs in Lithuania. Clinically sick adult dogs suffering from infections (n=214) and bitches
with reproductive disorders (n=36) from kennels were selected for the study. Samples (n=192) from
the 250 tested (76.8%) dogs were positive for Staphylococcus spp. Molecular profiling using the
species-specific nuc gene identified 51 isolates as S. pseudintermedius (26.6% from a total number of
isolated staphylococci) of which 15 isolates were identified as MRSP. Ten MRSP isolates were
isolated from bitches with reproductive disorders from two large breeding kennels. Data on suscepti-
bility of S. pseudintermedius to different antimicrobials revealed that all isolates were susceptible to
vancomycin, daptomycin and linezolid. Two isolates (3.9%) were resistant to rifampicin. A high
resistance was seen towards penicillin G (94.1%), tetracycline (64.7%) and macrolides (68.7%).
Resistance to fluoroquinolones ranged from 25.5% (gatifloxacin) to 31.4% (ciprofloxacin). The most
prevalent genes encoding resistance included blaZ, aac(6’)-Ie-aph(2’’)-Ia, mecA, and tet(M). The
Luk-I gene encoding a leukotoxin was detected in 29% of the isolates, whereas the siet gene encoding
exfoliative toxin was detected in 69% of the S. pseudintermedius isolates. This report of MRSP in
companion animals represents a major challenge for veterinarians in terms of antibiotic therapy and is
a concern for both animal and public health.
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Introduction
Staphylococcus pseudintermedius is an important
opportunistic pathogen of companion animals, es-
pecially dogs (van Duijkeren et al. 2011). Canine in-
fections caused by S. pseudintermedius are mostly skin
infections, endometritis, cystitis and other less fre-
quent infections (Cox et al. 1984, Morris et al. 2006).
S. pseudintermedius has various virulence factors, in-
cluding some that are closely related to the virulence
factors of S. aureus (Futagawa-Saito et al. 2004b, Fit-
zgerald 2009). It produces enzymes such as coagulase,
protease, thermonuclease and toxins, including
haemolysins and exfoliative toxins (Fitzgerald 2009,
Ben Zakour 2011). S. pseudintermedius also produces
a leucotoxin known as Luk-I, which is very similar to
Panton-Valentine leucocidin (PVL) from S. aureus
(Futagawa-Saito et al. 2009, Futagawa Saito et al.
2004a).
Methicillin-resistant S. pseudintermedius (MRSP)
has posed an increasing therapeutic challenge because
of its limited treatment options. Colonization and in-
fection caused by MRSP has been described in dogs,
cats, horses, birds and humans. This fact demonstrates
the zoonotical potential of S. pseudintermedius. It is
also known that dogs can carry the same or similar
MRSP strains for months without active infection.
Several reports on isolates not susceptible to any anti-
microbials authorized for use in veterinary medicine
have been published causing veterinarians to consider
using antimicrobials authorized for human medicine
only. Good veterinary practice requires the use of
antimicrobial treatment after correct diagnosis and
susceptibility testing. However, reliable commercial
identification systems for fast and correct identifica-
tion of S. pseudintermedius are not currently available.
In many cases, isolates will be erroneously identified
as S. intermedius or S. aureus.
MRSP isolates are characterized by the presence
of the mecA gene, which is located on staphylococcal
cassette chromosome mec (SCCmec) elements and
confers resistance to all f-lactam antibiotics. In addi-
tion to mecA, MRSP also may contain a wide range of
antibiotic resistance genes. In addition to β-lactam re-
sistance, resistance to 11 other antimicrobials was ob-
served in a study of 103 epidemiologically unrelated
MRSP isolates from dogs from Canada, the USA, De-
nmark, Germany, France, Italy, Sweden, Switzerland
and the Netherlands. The resistance of S. pseudinter-
medius depends on geographical distribution as well
as on other factors – thus, it is important to obtain
data from different countries to better understand the
epidemiological spread of resistance.
The aim of this study was to characterize
Staphylococcus pseudintermedius in sick Lithuanian
dogs for antimicrobial resistance and virulence factors
with a special focus on methicillin-resistant (MRSP)
strains.
Materials and Methods
The investigations were carried out at the
Lithuanian University of Health Sciences, Institute of
Microbiology and Virology.
Sample collection
Two hundred and fifty dogs were randomly se-
lected from small animal clinics located throughout
the country as well as in breeding kennels of
pure-breed dogs. Clinically sick adult dogs suffering
from skin infections (n=155), otitis (n=48), respir-
atory tract infections (n=11) and bitches with repro-
ductive disorders (metritis, temporal infertility, pre-
mature birth) (n=36) were selected for the study. The
age ranged between 2 and 8 years. Anamnesis data
showed that 190 dogs were untreated with antimic-
robials at least 6 months before sampling; 45 sick dogs
were treated over different intervals during the last
0-30 days before sampling. Fifteen bitches in kennels
were prophylactically treated with fluoroquinolones
and/or cephalosporins during the previous 3 months.
Sterile cotton swabs with transport media (TRANS-
WAB, Polysciences Inc.) or sterile syringes were used
for collection of clinical samples. These samples were
delivered to the laboratory on the same day. Only one
sample from the affected organ was taken from each
dog.
Bacteriological testing and DNA extraction
Samples were inoculated onto Mannitol-Salt Agar
(Liofilchem, Italy) and Mannitol-Salt Agar supple-
mented with oxacillin (Sigma-Aldrich). Suspected col-
onies of Staphylococcus spp. were tested for presump-
tive genus identification according to the production
of haemolysis, catalase, gram-staining, susceptibility
to furazolidone, morphology and growing characteris-
tics followed by a latex agglutination test („Staph
Latex Kit”, Microgen, UK). Presumptive S. pseudin-
termedius isolates were identified up to species level
using the RapID STAPH PLUS (Thermo Scientific)
identification system and ERIC® manufacturer’s sof-
tware.
DNA material for molecular testing was obtained
after bacterial lysis according to the extraction proto-
col prepared by the Community Reference Labora-
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Table 1. Oligonucleotide primers used in this study.
Primer Size, bp
name and T (oC)Sequence (5’ – 3’) Target gene Source
nuc1 TRGGCAGTAGGATTCGTTAA 926 (58) nuc Sasaki et al. 2010
nuc2 CTTTTGTGCTYCMTTTTGG
siet1 ATGGAAAATTTAGCGGCATCTGG 359 (56) exfoliative toxin Lautz et al. 2006
siet2 CCATTACTTTTCGCTTGTTGTGC
lukS1 TGTAAGCAGCAGAAAATGGGG 503 (57) lukS Futagawa-Saito et al. 2004-1
lukS2 GCCCGATAGGACTTCTTACAA
lukF1 CCTGTCTATGCCGCTAATCAA 572 (57) lukF Futagawa-Saito et al. 2004-1
lukF2 AGGTCATGGAAGCTATCTCGA
mecA1 GGGATCATAGCGTCATTATTC 527 (61) mecA Poulsen et al. 2003
mecA2 AACGATTGTGACACGATAGCC
mecC1 GCTCCTAATGCTAATGCA 204 (50) mecC Cuny et al. 2011
mecC2 TAAGCAATAATGACTACC
blaZ1 CAGTTCACATGCCAAAGAG 772 (50) blaZ Schnellmann et al. 2006
blaZ2 TACACTCTTGGCGGTTTC
tetM1 GTTAAATAGTGTTCTTGGAG 656 (45) tetM Aarestrup et al. 2000
tetM2 CTAAGATATGGCTCTAACAA
tetK1 TTAGGTGAAGGGTTAGGTCC 718 (55) tetK Aarestrup et al. 2000
tetK2 GCAAACTCATTCCAGAAGCA
aac6-aph2F CAGAGCCTTGGGAAGATGAAG 348 (61) aac(6’)-Ie-aph(2’’)-Ia Perreten et al. 2005
aac6-aph2R CCTCGTGTAATTCATGTTCTGGC
aph3-IIF CCGCTGCGTAAAAGATAC 609 (57) aph(3’)-IIIa Perreten et al. 2005
aph3-IIR GTCATACCACTTGTCCGC
dfrK1 GCTGCGATGGATAAGAACAG 214 (50) dfrK Kadlec and Schwarz 2010
dfrK2 GGACGATTTCACAACCATTAAAGC
ermA1 AAGCGGTAAAACCCCTCTGAG 442 (53) ermA Jensen et al. 2002
ermA2 TCAAAGCCTGTCGGAATTGG
ermC1 ATCTTTGAAATCGGCTCAGG 295 (48) ermC Jensen et al. 2002
ermC2 CAAACCCGTATTCCACGATT
ermB1 GGAACATCTGTGGTATGGCG 425 (48) ermB Jensen et al. 2002
ermB2 CATTTAACGACGAAACTGGC
msrA1 GCTTAACATGGATGTGG 1230 (55) msrA Perreten et al. 2005
msrA2 GATTGTCCTGTTAATTCCC
16S1 GTGCCAGCAGCCGCGGTAA 886 (61) 16S staph Poulsen et al. 2003
16S2 AGACCCGGGAACGTATTCAC
tory for Antimicrobial Resistance with slight modifi-
cations. Briefly, bacterial colonies were taken with
a bacteriological loop from the surface of Mueller
Hinton Agar and transferred to phosphate buffered
saline (pH 7.3). The content was centrifuged for
5 min. The supernatant was then discarded and the
pellet was re-suspended in Tris-EDTA (TE) buffer.
The suspension was heated using a Biosan (Latvia)
thermomixer to 100oC degrees for 10 minutes. The
boiled suspension was transferred directly onto ice
and diluted by 1:10 in TE.
Molecular testing
The species-specific thermonuclease (nuc) gene
for S. pseudintermedius as well as the 16S rRNR gene
was tested by PCR using oligonucleotides described
previously (Poulsen et al. 2003, Sasaki et al. 2010).
The positive control strain for S. pseudintermedius
(previously confirmed by sequencing analysis of the
16S rRNA gene) was obtained from the Laboratory of
Antimicrobial and Biocide Resistance, Technical Uni-
versity of Lisbon. Oligonucleotides used for detection
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of antimicrobial resistance and virulence genes are
presented in Table 1.
Antimicrobial susceptibility
Antimicrobial susceptibility testing was performed
using the broth microdilution method. Sensititre
plates and the ARIS 2X automated system (Thermo
Scientific) were used with the following antimic-
robials: ceftriaxone, daptomycin, gatifloxacin, ciprof-
loxacin, clindamycin, erythromycin, gentamicin, levof-
loxacin, linezolid, oxacillin, penicillin,
quinupristin/dalfopristin and rifampicin. Interpreta-
tion of results was carried out using the manufac-
turer’s software (SWIN®) adapted to clinical break-
points of the Clinical and Laboratory Standards Insti-
tute (CLSI). The quality control strain S. aureus
ATCC 29213 was included in each assay for validation
purposes.
PCR assays for antimicrobial and virulence genes
Detection of genes encoding antimicrobial resis-
tance (mecA, mecC, blaZ, tet(K), tet(M), erm(A),
erm(C), msrA/B, aac(6’)-Ie-aph(2’’)-Ia, aph(3’)-IIIa
and dfrK) was performed. Isolates were also tested for
the lukF/lukS genes encoding leukocidin Luk-I and
for the siet gene encoding exfoliative toxin. Annealing
temperatures and oligonucleotides used are presented
in Table 1. Positive control strains (previously con-
firmed by sequencing analysis) were obtained from
the Laboratory of Antimicrobial and Biocide Resis-
tance, Technical University of Lisbon.
Statistical analysis
Statistical analysis was performed using the „R
1.8.1” package (http://www.r-project.org/). Compari-
son between categorical variables was calculated using
the chi-square test and Fisher’s exact test. Results
were considered statistically significant if p<0.05.
Results
One hundred and ninety two samples from 250
tested (76.8%) were positive for the presence of
Staphylococcus species. The percentage was higher in
non-treated animals (89.5%). Fifty-four isolates did
not ferment mannitol on mannitol-salt agar, had
a positive reaction with Microgen Staph Latex Kit and
expressed a large double zone of haemolysis on
sheep-blood agar. Thirty-two isolates were initially
identified as S. intermedius using a biochemical identi-
fication system. Molecular typing using the
species-specific nuc gene identified 51 isolates as S.
pseudintermedius (26.6%) including those previously
identified as S. intermedius. Fifteen samples (29.4%)
from different dogs were able to grow on mannitol
salt agar supplemented with 2 mg/L oxacillin. The
mecA gene was detected in all of these isolates, all of
them being resistant to oxacillin and identified as
MRSP. The mecC gene was not detected. Ten MRSP
isolates were isolated in two kennels (previously
treated with fluoroquinolones and/or cephalosporins)
breeding Yorkshire terriers, French Bulldogs and
English Bulldogs (number of adult dogs in each ken-
nel was 18 and 22 respectively).
Table 2 presents data on the distribution of S.
pseudintermedius including MRSP isolates in dogs
with different clinical infections, together with the
number of isolates harbouring genes encoding pro-
duction of Luk-I and siet.
The data presented in Table 2 demonstrate that S.
pseudintermedius was isolated from dogs with differ-
ent clinical infections, although the highest frequency
of this species was detected in dogs with pyoderma.
Ten MRSP isolates were isolated in two large breed-
ing kennels from bitches with reproductive disorders.
Genes encoding production of Luk-I toxin were
not associated with any of the clinical infections
(p>0.5); however, the siet gene, responsible for the
production of an exfoliative toxin, was significantly as-
sociated with isolates from skin infections (p<0.01).
From all isolates, 68.6% had at least one gene respon-
sible for the production of toxins.
Data on antimicrobial susceptibility of the isolates
is presented in Table 3.
All S. pseudintermedius isolated strains were sus-
ceptible to vancomycin, daptomycin and linezolid.
Two isolates (3.9%) were resistant to rifampicin.
More frequent resistance was demonstrated to peni-
cillin (94.1%), tetracycline (64.7%) and macrolides
(68.7%). Resistance to fluoroquinolones was high and
ranged from 25.5% (gatifloxacin) to 31.4% (ciprof-
loxacin). Genes encoding resistance to separate
classes of antimicrobials were found in different
numbers (Table 3). The most prevalent genes in-
cluded blaZ, aac(6’)-Ie-aph(2’’)-Ia, mecA, and tet(M).
Discussion
Bacteria of the genus Staphylococcus are highly
prevalent in clinical samples from small animals. In
general, we found that 76.8% of the tested samples
were positive although the prevalence was higher in
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Table 2. Clinical infections associated with S. pseudintermedius including MRSP and presence of the genes encoding toxins.
Genes encoding toxins
lukS lukF siet
Number of Number of MRSP
S. pseudintermedius iso-
lates isolatesClinical disorder
Otitis 5 0 2 2 3
Pyoderma 24 4 6 6 22
Reproductive disorders 18 10 6 6 9
Other 4 1 1 1 1




resistanceClass of antimicrobials Antimicrobial
Penicillins Penicillin 3(5.9) – 48(94.1) blaZ (45)3
mecA (15)Oxacillin 36(70.6) – 15(29.4)
Cephalosporins Ceftriaxone 35(68.6) 3(5.9) 13(25.5)
Tetracyclines Tetracycline 18(35.3) – 33(64.7) tet(K) (6)
tet(M) (14)
Erythromycin 14(27.5) 1(2.0) 36(70.6) erm(A) (1)
Clindamycin 14(27.5) – 37(72.5) erm(C) (3)
Quinupristin/dalfopristin 48(94.1) 2(3.9) 1(2.0) msrA/B (6)
Macrolides, lincosamides
and streptogramins
DFR inhibitors Trimethoprim 36(70.6) – 15(29.4) dfrK (8)
Ciprofloxacin 35(68.7) – 16(31.4) nt
Fluoroquinolones Gatifloxacin 38(74.5) – 13(25.5) nt
Levofloxacin 36(70.6) 1(2.0) 14(27.5) nt
Rifamycins Rifampicin 49(96.1) – 2(3.9) nt
Lipopeptides Daptomycin 51(100) – 0(0) nt
Glycopeptides Vancomycin 51(100) – 0(0) nt
Aminoglycosides Gentamicin 25(49.0) 7(13.7) 19(37.6) aac(6’)-Ie-aph(2’’)-Ia (16)
aph(3’)-IIIa (11)
Oxazolidinones Linezolid 51(100) – 0(0) nt
1 S – susceptible; I – intermediate susceptible; R – resistant
2 nt – not tested
3 in parentheses – number of isolates harbouring the tested genes
non-treated animals (89.5%). Such data are consistent
with data obtained by other authors (Griffeth 2008,
Penna et al. 2010). We focused on S. pseudintermedius
since it is the most prevalent species in dogs (Haus-
child and Wójcik 2007, Penna et al. 2010, Bannoehr
and Guardabassi 2012). Moreover, S. pseudinter-
medius is often reported as methicillin-resistant with
co-resistance to different classes of antimicrobials
other than beta-lactams (Perreten et al. 2010, Weese
and Duijkeren 2010, Windahl et al. 2012). The numb-
er of S. pseudintermedius isolates (26.6%) revealed
that this species is widely distributed in clinical
samples from dogs although there are other species
that are prevalent as well (data not presented).
There are different data about the prevalence of
S. pseudintermedius described by other authors. For
example, Feng et al. (2012) reported a prevalence of
18.3%, while Garbacz et al. (2013) described it to be
51.8.4% of tested animals. Data on the prevalence
might depend on study design, identification methods,
sampling, animal health status and other factors. It is
known that classical biochemical tests for species
identification are not always capable of identifying S.
pseudintermedius (van Duijkeren et al. 2011). We
found this to be true as well. Certain substrates
(carbohydrates and amino acids) are weakly fer-
mented and thus interpretation of results based on
a colour index is subjective.
In our study S. pseudintermedius was isolated from
dogs with different clinical infections, and thus we de-
tected genes encoding for pathogenicity factors. We
detected a high frequency (68.8%) of luk and/or siet
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genes in S. pseudintermedius isolates in Lithuania. In-
terestingly, all isolates that harboured both lukF and
lukS genes harboured the siet gene as well (p<0.01)
but not vice versa. To our knowledge such a statistical
relationship had not been detected before. Statisti-
cally reliable results were obtained when studying the
association between the presence of siet gene in iso-
lates from skin infections compared with isolates ob-
tained from other types of infection. This agrees with
the fact that the exfoliative toxin is a virulence factor
of S. pseudintermedius involved in canine pyoderma. It
is mainly found among isolates from skin infections
(Lautz et al. 2006, Iyori et al. 2010). The luk genes
were found in different S. pseudintermedius strains ir-
respective of the source of isolation. The Luk-I shows
strong leucotoxicity towards various polymorphonuc-
lear cells (Futagawa et al. 2004a). It might be respon-
sible for invasion of the host by suppressing its cellular
immunity and could be produced by different strains
of S. pseudintermedius.
Data on antimicrobial susceptibility revealed that
S. pseudintermedius most frequently has resistance to
antimicrobials used in dogs including penicillins (re-
sistance attributed to blaZ gene), tetracyclines (tet(K)
and tet(M) genes) and macrolides (ermA and ermC
genes).
The ermB gene was not detected. In fact, this gene
is rarely isolated (1.9%) in MRSP isolates from Euro-
pe and North America collected previously (Perreten
et al. 2010), except in Norway where resistance of S.
pseudintermedius was attributed to the ermB gene
(Norstrom et al. 2009). A high rate of resistance to
fluoroquinolones (25.5-31.4%) was also recorded. Re-
sistance mechanisms to fluoroquinolones of S.
pseudintermedius are well described (Descloux et al.
2008). The high frequency of resistance to
fluoroquinolones found here could be explained in
that fluoroquinolones are frequently used to treat dog
infections especially in cases with unsatisfactory clini-
cal practice where broad-spectrum antimicrobials are
selected for treatment without sending clinical ma-
terial to a laboratory for diagnosis and antibiogram.
Resistance of S. pseudintermedius isolates to gen-
tamicin was also high (37.6%). The genes responsible
for encoding resistance to aminoglycosides
aac(6’)-Ie-aph(2’’)-Ia and aph(3’)-IIIa were detected
here. The same genes were recently found in most
isolates of enterococci isolated from diseased cows,
pigs and poultry in Lithuania (Seputiene et al. 2012).
Those genes encoding resistance to aminoglycosides
were also found in S. pseudintermedius in other coun-
tries (Kadlec et al. 2010). It is interesting that resistant
isolates to gentamicin harboured the siet gene as
a rule (p<0.01).
In this study, 29.4% of S. pseudintermedius strains
were identified as MRSP. Lithuania-specific data on
methicillin resistant staphylococci isolated from ani-
mals is scarce – the first case of methicillin resistance
in livestock was only reported in 2011, when MRSA
ST398 strains were found and characterised in pigs
(Ruzauskas et al. 2013). To the best of our knowledge,
this study is the first Lithuanian study where MRSP
strains were confirmed using molecular methods. This
high frequency of MRSP in dogs could be explained
as follows: first, only diseased animals were involved
in the study and most of them were being treated or
had been treated previously with an antimicrobial.
Second, as proven before, the use of fluoroquinolones
and cephalosporins might select for antimicrobial re-
sistant bacteria (SAGAM 2009, van Duijkeren et al.
2011) and some of these dogs had been previously
treated with some of these antimicrobial drugs. Final-
ly, 10 MRSP isolates were isolated on two large breed-
ing kennels from bitches with reproductive disorders
in which the owners irregularly used antimicrobials,
including enrofloxacin and/or cefovecin for ‘‘better re-
productive performance”. Such inappropriate use of
antimicrobials possibly led to high resistance rates of
MRSP in these kennels. Thus, breeding kennels might
be a reservoir of MRSP strains and may pose a risk for
spreading such strains during mating. There is no re-
quirement for reporting MRSP or MRSA strains
prevalent in kennels. Thus, other breeders have no
information about the status of such animals. Atten-
tion should be paid to this problem since methicil-
lin-resistant staphylococci pose a risk not only to ani-
mals but also to humans (Catry et al. 2010, Stegmann
et al. 2010, van Duijkeren et al. 2011).
Our findings indicate that staphylococci including
S. pseudintermedius are very common in clinical
samples from diseased dogs. The prevalence of genes
encoding toxins in S. pseudintermedius is high as also
the resistance rates to some critically important anti-
microbials such as beta-lactams and fluoroquinolones.
Isolates remain susceptible only to those antimic-
robials that are still banned from veterinary use
(linezolid, vancomycin, and daptomycin). Such anti-
biotics should be reserved for humans and control of
their use in kennels needs to be improved. Monitoring
of antimicrobial resistance in kennels should be per-
formed routinely and should include control options
to avoid the spread of resistance.
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